Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
J Thorac Imaging ; 39(4): 201-207, 2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38664903

RESUMEN

PURPOSE: To perform qualitative and quantitative evaluation of low-monoenergetic images (50 KeV) compared with conventional images (120 kVp) in pulmonary embolism (PE) studies and to determine the extent and clinical relevance of these differences as well as radiologists' preferences. MATERIALS AND METHODS: One hundred fifty CT examinations for PE detection conducted on a single-source dual-energy CT were retrospectively evaluated. Attenuation, contrast-to-noise-ratio, and signal-to-noise-ratio were obtained in a total of 8 individual pulmonary arteries on each exam-including both central (450/1200=37.5%) and peripheral (750/1200=62.5%) locations. Results were compared between the conventional and low-monoenergetic images. For quality assessment, 41 images containing PE were presented side-by-side as pairs of slices in both conventional and monoenergetic modes and evaluated for ease in embolus detection by 9 radiologists: cardiothoracic specialists (3), noncardiothoracic specialists (3), and residents (3). Paired samples t tests, a-parametric Wilcoxon test, McNemar test, and kappa statistics were performed. RESULTS: Monoenergetic images had an overall statistically significant increased average ratio of 2.09 to 2.26 ( P <0.05) for each measured vessel attenuation, with an increase in signal-to-noise ratio (23.82±9.29 vs. 11.39±3.2) and contrast-to-noise ratio (17.17±6.7 vs 7.27±2.52) ( P <0.05). Moreover, 10/150 (6%) of central pulmonary artery measurements considered suboptimal on conventional mode were considered diagnostic on the monoenergetic images (181±14.6 vs. 387.7±72.4 HU respectively, P <0.05). In the subjective evaluation, noncardiothoracic radiologists showed a preference towards low-monoenergetic images, whereas cardiothoracic radiologists did not (74.4% vs. 57.7%, respectively, P <0.05). CONCLUSIONS: The SNR and CNR increase on monoenergetic images may have clinical significance particularly in the setting of sub-optimal PE studies. Noncardiothoracic radiologists and residents prefer low monoenergetic images.


Asunto(s)
Arteria Pulmonar , Embolia Pulmonar , Imagen Radiográfica por Emisión de Doble Fotón , Humanos , Arteria Pulmonar/diagnóstico por imagen , Femenino , Embolia Pulmonar/diagnóstico por imagen , Estudios Retrospectivos , Masculino , Persona de Mediana Edad , Anciano , Adulto , Imagen Radiográfica por Emisión de Doble Fotón/métodos , Angiografía por Tomografía Computarizada/métodos , Anciano de 80 o más Años , Tomografía Computarizada por Rayos X/métodos , Relación Señal-Ruido , Interpretación de Imagen Radiográfica Asistida por Computador/métodos , Reproducibilidad de los Resultados , Variaciones Dependientes del Observador
2.
Int J Nanomedicine ; 6: 2859-64, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22131831

RESUMEN

In recent years, advances in molecular biology and cancer research have led to the identification of sensitive and specific biomarkers that associate with various types of cancer. However, in vivo cancer detection methods with computed tomography, based on tracing and detection of these molecular cancer markers, are unavailable today. This paper demonstrates in vivo the feasibility of cancer diagnosis based on molecular markers rather than on anatomical structures, using clinical computed tomography. Anti-epidermal growth factor receptor conjugated gold nanoparticles (30 nm) were intravenously injected into nude mice implanted with human squamous cell carcinoma head and neck cancer. The results clearly demonstrate that a small tumor, which is currently undetectable through anatomical computed tomography, is enhanced and becomes clearly visible by the molecularly-targeted gold nanoparticles. It is further shown that active tumor targeting is more efficient and specific than passive targeting. This noninvasive and nonionizing molecular cancer imaging tool can facilitate early cancer detection and can provide researchers with a new technique to investigate in vivo the expression and activity of cancer-related biomarkers and molecular processes.


Asunto(s)
Carcinoma de Células Escamosas/diagnóstico por imagen , Medios de Contraste/farmacocinética , Sistemas de Liberación de Medicamentos/métodos , Oro/farmacocinética , Neoplasias de Cabeza y Cuello/diagnóstico por imagen , Nanopartículas del Metal/química , Imagen Molecular/métodos , Tomografía Computarizada por Rayos X/métodos , Animales , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patología , Línea Celular Tumoral , Medios de Contraste/química , Receptores ErbB/antagonistas & inhibidores , Oro/química , Neoplasias de Cabeza y Cuello/metabolismo , Neoplasias de Cabeza y Cuello/patología , Humanos , Ratones , Ratones Desnudos , Tamaño de la Partícula , Carcinoma de Células Escamosas de Cabeza y Cuello , Trasplante Heterólogo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA